Biomarkers for prostate cancer: present challenges and future opportunities.
about
Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer.The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the LiteratureOverexpression of TFF3 is involved in prostate carcinogenesis via blocking mitochondria-mediated apoptosis
P2860
Biomarkers for prostate cancer: present challenges and future opportunities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarkers for prostate cancer: present challenges and future opportunities.
@en
Biomarkers for prostate cancer: present challenges and future opportunities.
@nl
type
label
Biomarkers for prostate cancer: present challenges and future opportunities.
@en
Biomarkers for prostate cancer: present challenges and future opportunities.
@nl
prefLabel
Biomarkers for prostate cancer: present challenges and future opportunities.
@en
Biomarkers for prostate cancer: present challenges and future opportunities.
@nl
P2860
P356
P1433
P1476
Biomarkers for prostate cancer: present challenges and future opportunities.
@en
P2093
Julio M Pow-Sang
Pranav Sharma
P2860
P356
10.4155/FSO.15.72
P577
2015-12-17T00:00:00Z